Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that its Selenia Dimensions 2D/3D mammography system won a gold Medical Design Excellence Award (MDEA) at the Medical Design and Manufacturing East 2011 Conference and Exposition.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/50095/
In a bold move to address the healthcare affordability crisis, Blue Shield of California Chairman & CEO Bruce Bodaken announced a pledge today that Blue Shield will limit its annual net income to no more than 2 percent of revenue. This commitment will apply retroactively to income earned in 2010, when Blue Shield’s net income exceeded the 2 percent target by $180 million. That amount will go back to Blue Shield’s customers and the community.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bsc/50440/
Thirty-six million Americans suffer from migraines, leading to more than $20 billion in medical expenses and costs related to lost productivity each year¹. In recognition of National Migraine Awareness Month and the significant unmet medical needs of migraine patients, Zogenix, Inc. (NASDAQ: ZGNX) is highlighting the importance of selecting the appropriate medication for a patient’s “treatment toolbox” to address specific types of migraine episodes.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/zogenix/50344/
The Starkey Hearing Foundation and its Israeli partners concluded today its Israel-Palestine Hearing Mission of Peace in the West Bank region, fitting more than 1,000 Palestinian children and adults with hearing devices. The Starkey Hearing Foundation hopes the three-day effort will promote greater communication and understanding among the local communities through improved hearing.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/starkeyhearingfoundation/50402/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Conoce las Preguntas, una nueva campaña de multimedia en español, anunciada hoy por la Agency for Healthcare Research and Quality (Agencia para la Investigación y Calidad de los Servicios de Salud
Bayer HealthCare’s Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release™ Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets.
With the introduction of aspirin in 1899, Bayer offered one of the first widely accessible analgesics, or pain relievers, to consumers. Today, Bayer's overall global Aspirin business continues to grow, and had double-digit, year-on-year sales growth in Q1 2011. Yet, while Bayer continues to be a leader in the category, for many U.S. consumers, Bayer Aspirin is primarily synonymous with cardiovascular use. Now, through a combination of technological innovation and rich analgesic heritage, Bayer is introducing a new standard in aspirin for tough pain relief with Bayer Advanced Aspirin.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bayer/50414/
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, has announced the first nine U.S. cities for a series of evening events to introduce clinicians to the Selenia Dimensions 2D/3D breast tomosynthesis system and gain hands-on experience with this new technology.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/50094/
Bill Gates, co-chair of the Bill & Melinda Gates Foundation, called on government leaders to increase their investments in vaccines and to hold themselves accountable for extending the benefits of vaccines to every child.
In a keynote address at the 64th World Health Assembly, an annual gathering of health ministers and global health leaders, Gates laid out his vision for the impact that broadening access to vaccines can have on the world. “Strong immunization systems will put an end to polio and help us reach all children with five to six new vaccines,” Gates said. “We can save four million lives by 2015, and 10 million lives by 2020.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gatesfoundation/49363/
GRAMMY® Award winner and the national spokesperson for EUFLEXXA® (1 percent sodium hyaluronate), Gloria Gaynor has partnered with Ferring Pharmaceuticals Inc. to launch a five-part exercise video series that encourages people with pain due to osteoarthritis (OA) of the knee to maintain healthy, active lifestyles.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/euflexxa/49736/
The American Cancer Society today announces the development of a new documentary film in collaboration with Academy Award-winning Actress Hilary Swank to inspire women nationwide to make their own health a priority and take everyday steps to help prevent cancer. Swank is executive producer of the film alongside Molly Mickler Smith of 2S Films and Go Go Luckey Entertainment, and the film is directed by Tina Gazzerro of Go Go Luckey Entertainment. The film helps mark the first anniversary of Choose You, a nationwide movement created by the American Cancer Society to raise awareness that 1 in 3 women will get cancer in her lifetime and the actions women can take today to help change that statistic. More than half of cancer deaths could be prevented if people maintained a healthy weight through diet and regular exercise, avoided tobacco products and got recommended cancer screening tests.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cancer/50276/
PSI, a leading international health organization with programs in 67 countries, launches the latest issue of its global health magazine Impact, which answers the question: What is the future of international development?
Fifty years ago, President John F. Kennedy created the U.S. Agency of International Development (USAID) to address Americans’ increasing dissatisfaction with foreign aid. Today the U.S. spends less than 1% of its total budget on foreign aid. How will sweeping new USAID reforms enable the Agency to make the most of taxpayer money? And how are international organizations approaching development on the ground?
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/psi/47715/
